Three years ago today, our final Phase IIA trial results were released. Since then, we have still not put a jab in an arm for our next trial, despite these outstanding results. I will admit back then I did not think not starting the trial by now was even a remote possibility. Who is to blame?
Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-223
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.0¢ | $168.5K | 1.260M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 633259 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 874939 | 7 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |